Explore more publications!
Maryland Tribune
Got News to Share?

Maryland Tribune: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Maryland Tribune.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on November 6, 2025

NeuroCytonix Authorized by COFEPRIS to Launch Neuro-Restorative Treatment Program in Mexico
November 6, 2025

NeuroCytonix Authorized by COFEPRIS to Launch Neuro-Restorative Treatment Program in Mexico

Indeterminate EIN Presswire
EpiWatch To Be at Epilepsy Awareness Day at Disneyland, Highlighting Seizure Detection and Alerting App on Apple Watch
November 6, 2025

EpiWatch To Be at Epilepsy Awareness Day at Disneyland, Highlighting Seizure Detection and Alerting App on Apple Watch

Indeterminate EIN Presswire
Engineered Stones Gain Ground Owing to their Durability and Longevity - Artelye Introduces Quartz Countertops
November 6, 2025

Engineered Stones Gain Ground Owing to their Durability and Longevity - Artelye Introduces Quartz Countertops

Indeterminate EIN Presswire
Three Attorneys from TNS Family Law Recognized in the 2026 Edition of The Best Lawyers in America
November 6, 2025

Three Attorneys from TNS Family Law Recognized in the 2026 Edition of The Best Lawyers in America

Indeterminate EIN Presswire
MarketWise Reports Net Revenue of $81.3 Million and Net Income of $17.9 Million for Third Quarter 2025; Third Quarter Billings Increased 30% YoY; Announced Quarterly and Special Dividend Totaling $0.40 per Class A Share, for Total FY 2025 Dividends of…
November 6, 2025

MarketWise Reports Net Revenue of $81.3 Million and Net Income of $17.9 Million for Third Quarter 2025; Third Quarter Billings Increased 30% YoY; Announced Quarterly and Special Dividend Totaling $0.40 per Class A Share, for Total FY 2025 Dividends of…

Indeterminate GlobeNewswire
Host Hotels & Resorts Provides Updated Third Quarter 2025 Investor Presentation
November 6, 2025

Host Hotels & Resorts Provides Updated Third Quarter 2025 Investor Presentation

Indeterminate GlobeNewswire
MacroGenics to Participate in the Stifel 2025 Healthcare Conference
November 6, 2025

MacroGenics to Participate in the Stifel 2025 Healthcare Conference

Indeterminate GlobeNewswire
Elutia Reports Third Quarter 2025 Financial Results; Closes $88 Million Sale of BioEnvelope Business to Boston Scientific Corporation; Funds NXT-41x Development
November 6, 2025

Elutia Reports Third Quarter 2025 Financial Results; Closes $88 Million Sale of BioEnvelope Business to Boston Scientific Corporation; Funds NXT-41x Development

Indeterminate GlobeNewswire
FDA Awards Second Batch of National Priority Vouchers
November 6, 2025

FDA Awards Second Batch of National Priority Vouchers

Indeterminate GlobeNewswire
Huntress Named Inc. Power Partner for Third Consecutive Year
November 6, 2025

Huntress Named Inc. Power Partner for Third Consecutive Year

Indeterminate GlobeNewswire
Webinar to Explore Solutions for Sustainable Energy and Technology to Power a Resilient Economy
November 6, 2025

Webinar to Explore Solutions for Sustainable Energy and Technology to Power a Resilient Economy

Indeterminate GlobeNewswire
Avalo Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Updates
November 6, 2025

Avalo Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Updates

Indeterminate GlobeNewswire
Altimmune Announces Third Quarter 2025 Financial Results and Business Updates
November 6, 2025

Altimmune Announces Third Quarter 2025 Financial Results and Business Updates

Indeterminate GlobeNewswire
Cartesian Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
November 6, 2025

Cartesian Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions